Dysregulation of smoldering multiple myeloma (SMM) progression to multiple myeloma (MM) via modulation of AKT kinase, proinflammatory cytokines, and insulin-like growth factor-1 (IGF-1) in human immunodeficiency virus-1 SMM ( HIVSMM ) patients treated with adjuvant selenomethionine (Se-Met) ritonavir-based HAART.

Eugene McPherson,Ervido Mejia,P. Tassy

Dysregulation of smoldering multiple myeloma (SMM) progression to multiple myeloma (MM) via modulation of AKT kinase, proinflammatory cytokines, and insulin-like growth factor-1 (IGF-1) in human immunodeficiency virus-1 SMM ( HIVSMM ) patients treated with adjuvant selenomethionine (Se-Met) ritonavir-based HAART.

2013

Eugene McPherson
Ervido Mejia
P. Tassy

e19540 Background: Multiple myeloma is a B-cell malignancy involving germinal center B cells characterized by urinary monoclonal proteins, osteolytic bone lesions and infiltration of bone marrow wi...

Keywords:

Pathology
Protein kinase B
Proinflammatory cytokine
Ritonavir
Insulin-like growth factor
Human immunodeficiency virus 1
Cancer research
Multiple myeloma
Kinase
Medicine
Adjuvant
human immunodeficiency virus

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations